Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Sept 2026 for Caris Life Sciences, Inc., €851k.
Filing timeline
BuySaleBrian J. Brille
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Brian J. Brille: trading record in brief
This profile gathers the share dealings of Brian J. Brille in Caris Life Sciences, Inc. The record holds 7 filings, for trades running from 18 June 2025 to 17 September 2026.
The open-market side counts 1 purchase for €547k alongside 1 sale for €10.6M. On balance, insiders were net sellers of €10.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 17 September 2026, reports an option exercise of €851k in Caris Life Sciences, Inc. The last insider purchase was made public on 23 June 2025, 487 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brian J. Brille
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
400,000 shares@ US$2.44Common StockSEC:0002071959-26-000008:0
400,000 shares@ US$30.3302Common StockSEC:0002071959-26-000008:1
83,162 shares0Common StockSEC:0002071959-26-000004:0
650 shares0Common StockSEC:0002071959-25-000009:0
132,428 shares0Common StockSEC:0001104659-25-061802:0
5 of 5 declarations
